| Late significant | Late significant | p Value | |
| TR (−) (n = 589) | TR (+) (n = 49) | ||
| Age, years | 50 (14) | 55 (14) | 0.018 |
| Female gender, n | 245 (42%) | 37 (76%) | <0.001 |
| Atrial fibrillation, n | 206 (35%) | 33 (67%) | <0.001 |
| Rheumatic aetiology, n | 249 (42%) | 36 (74%) | <0.001 |
| Underlying valvular lesion | 0.006 | ||
| Mitral, n | 292 (50%) | 31 (63%) | |
| Aortic, n | 214 (36%) | 7 (14%) | |
| Both, n | 83 (14%) | 11 (22%) | |
| Surgical procedures | |||
| CABG, n | 27 (5%) | 4 (8%) | 0.287 |
| Maze, n | 50 (9%) | 3 (6%) | 0.788 |
| CPB time, min | 122 (56) | 125 (57) | 0.740 |
| Aortic clamp time, min | 83 (42) | 83 (40) | 0.913 |
| Preoperative data | |||
| Left atrial AP diameter, mm | 52 (11) | 57 (14) | 0.001 |
| RV dimension, mm | 18 (4) | 17 (4) | 0.924 |
| Left ventricular EF, % | 57 (10) | 58 (8) | 0.597 |
| TR grade | 0.8 (0.7) | 1.0 (0.6) | 0.007 |
| TV annulus diameter, mm | 31 (5) | 32 (6) | 0.723 |
| Peak PG of TR, mm Hg | 30 (12) | 30 (10) | 0.909 |
| Immediate echocardiographic changes (Δ; post–preoperative) | |||
| ΔLVIDs, mm | −2 (6) | −4 (7) | 0.031 |
| ΔLVIDd, mm | −8 (8) | −9 (8) | 0.615 |
| ΔLV EF, % | −7 (12) | −5 (11) | 0.429 |
| ΔRV dimension, mm | −2 (3) | −1 (3) | 0.782 |
| Late follow-up data | |||
| Atrial fibrillation, n | 169 (28%) | 33 (67%) | <0.001 |
| Left atrial AP diameter, mm | 45 (8) | 53 (12) | <0.001 |
| Left ventricular EF, % | 58 (9) | 58 (8) | 0.671 |
| TV annulus diameter, mm | 35 (5) | 40 (7) | <0.001 |
| Peak PG of TR, mm Hg | 24 (6) | 31 (11) | <0.001 |
| Left-sided valvular dysfunction | |||
| Prosthesis malfunction, n | 27 (5%) | 7 (14%) | 0.011 |
| New valvular lesion, n | 3 (1%) | 2 (4%) | 0.050 |
Continuous variables are expressed as mean (SD).
AP, anterior–posterior; CABG, coronary artery bypass graft; CPB, cardiopulmonary bypass; EF, ejection fraction; LVIDd, left ventricular diastolic dimension; LVIDs, left ventricular systolic dimension; PG, pressure gradient; RV, right ventricle; TV, tricuspid valve.